EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Detection of Antibodies against Feline Morbillivirus by Recombinant Matrix Enzyme-Linked Immunosorbent Assay

Surangkanang Chaiyasak iD, Chutchai Piewbang iD, Jadsada Ratthanophart iD, Navapon Techakriengkrai, Kittipong Rattanaporn, Somporn Techangamsuwan iD

Viruses · 2024

DOI: 10.3390/v16081339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Surangkanang Chaiyasak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand. Hauptthemen laut MEDLINE: Enzyme-Linked Immunosorbent Assay, Antibodies, Viral, Morbillivirus, Cat Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand Science Research and Innovation Fund Chulalongkorn University (HEA663100104), National Research Council of Thailand (NRCT): R. Thanawongnuwech NRCT Senior Scholar 2022.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Feline morbillivirus (FeMV) has been associated with feline health, although its exact role in pathogenesis is still debated. In this study, an indirect enzyme-linked immunosorbent assay (i-ELISA) targeting a recombinant matrix protein of FeMV (rFeMV-M) was developed and assessed in comparison to a Western blotting (WB) assay. The i-ELISA was evaluated using blood samples from 136 cats that were additionally tested with real-time reverse-transcription PCR (RT-qPCR). The i-ELISA exhibited a sensitivity of 90.1%, specificity of 75.6%, positive predictive value of 88.2%, and negative predictive value of 79.1%. The agreement between i-ELISA and WB analyses was substantial (a κ coefficient of 0.664 with a 95% confidence interval of 0.529 to 0.799). Within the study group, 68.4% (93/136) of the cats were serologically positive in the i-ELISA and 66.9% (91/136) in the WB assay, with 11.8% (11/93) of false positivity with the i-ELISA. However, only 8.1% (11/136) of the cats tested positive for FeMV using RT-qPCR (p < 0.001). The developed i-ELISA proved effective in identifying FeMV-infected cats and indicated the prevalence of FeMV exposure. Combining FeMV antibody detection through i-ELISA with FeMV RT-qPCR could offer a comprehensive method to determine and monitor FeMV infection status. Nevertheless, this assay still requires refinement due to a significant number of false positive results, which can lead to the misdiagnosis of cats without antibodies as having antibodies. This study also provided the first evidence of seroprevalence against FeMV among cat populations in Thailand, contributing valuable insights into the geographic distribution and prevalence of this virus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enzyme-Linked Immunosorbent AssayAntibodies, ViralMorbillivirusCat DiseasesSensitivity and SpecificityMorbillivirus InfectionsAnimalsCatsRecombinant ProteinsFemaleBlotting, WesternMaleViral Matrix Proteins

Stichwörter der Autor:innen

Western blot analysisfeline morbillivirusindirect ELISArecombinant matrix protein

Substanzen

Antibodies, ViralRecombinant ProteinsViral Matrix Proteins

Autor:innen und Institutionen

  • Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand.
  • Veterinary Infectious Diseases Research Unit, Faculty of Veterinary Science, Mahasarakham University, Maha Sarakham 44000, Thailand.
  • Animal Virome and Diagnostic Development Research Unit, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand.
  • National Institute of Animal Health, Department of Livestock Development, Bangkok 10900, Thailand.
  • Department of Veterinary Microbiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand.
  • Department of Biotechnology, Faculty of Agro-Industry, Kasetsart University, Bangkok 10900, Thailand.

ORCID-Profile: Surangkanang Chaiyasak, Chutchai Piewbang, Jadsada Ratthanophart, Somporn Techangamsuwan

Förderung

  • Thailand Science Research and Innovation Fund Chulalongkorn University (HEA663100104)
  • National Research Council of Thailand (NRCT): R. Thanawongnuwech NRCT Senior Scholar 2022

Zitieren

APA

Chaiyasak, S., Piewbang, C., Ratthanophart, J., Techakriengkrai, N., Rattanaporn, K., & Techangamsuwan, S. (2024). Detection of Antibodies against Feline Morbillivirus by Recombinant Matrix Enzyme-Linked Immunosorbent Assay. Viruses. https://doi.org/10.3390/v16081339

Vancouver

Chaiyasak S, Piewbang C, Ratthanophart J, Techakriengkrai N, Rattanaporn K, Techangamsuwan S. Detection of Antibodies against Feline Morbillivirus by Recombinant Matrix Enzyme-Linked Immunosorbent Assay. Viruses. 2024. doi:10.3390/v16081339

BibTeX
@article{Chaiyasak2024,
  author = {Chaiyasak, Surangkanang and Piewbang, Chutchai and Ratthanophart, Jadsada and Techakriengkrai, Navapon and Rattanaporn, Kittipong and Techangamsuwan, Somporn},
  title = {Detection of Antibodies against Feline Morbillivirus by Recombinant Matrix Enzyme-Linked Immunosorbent Assay},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16081339}
}
Kostenlos starten →